Objectives Chemerin is a recently discovered adipokine that regulates adipocyte
differentiation and modulates chemotaxis and activation of dendritic cells and macrophages …

Objective This study aimed to confirm existing assumptions about the associations of
circulating chemerin with inflammatory and metabolic parameters in a large population …

Chemerin is a newly discovered adipokine which has been found closely associated with
obesity, metabolic syndrome (MetS), and inflammatory status. This study will investigate …

Objective Patients with metabolic syndrome (MetS) are at a high risk for developing
atherosclerosis and cardiovascular disease. Serum levels of chemerin have been found …

Background Chemerin is a novel adipokine that is associated with inflammation and
adipogenesis. However, it remains unclear whether chemerin is involved in patients with …

Background: Chemerin is a new adipokine elevated in states of obesity and metabolic
syndrome. In order to identify the role of chemerin in hypertension, we conducted a case …

Context: Chemerin is a novel adipokine previously associated with metabolic syndrome
phenotypes in a small sample of subjects from Mauritius. Objective: The aim of the study was …

Objective Chemerin, a recently discovered adipocytokine, may be linked to obesity and
obesity‐associated metabolic complications. However, the relationship between visceral fat …

Obesity and metabolic syndrome (MetS) are considered chronic inflammatory states.
Chemerin, a novel adipokine, may play an important role in linking MetS and inflammation …

Chemerin is a secreted protein with a complex but well-established role in immune function.
Parallel lines of investigation also support the notion that chemerin is a novel adipokine that …